Carboplatin/Etoposide/VincristineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2047卷 / 1期

关键词：

D O I：

10.1007/s40278-025-77889-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：104 / 104

相关论文

共 50 条

[31] Cyclophosphamide/vincristineLack of efficacy: case report
Reactions Weekly, 2025, 2046 (1) : 120 - 120
[32] Topotecan/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 479 - 479
[33] Dexamethasone/vincristineLack of efficacy: case report
Reactions Weekly, 2023, 1971 (1) : 102 - 102
[34] Bendamustine/VincristineLack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 90 - 90
[35] Rituximab/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1883 (1) : 325 - 325
[36] Ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1887 (1) : 371 - 371
[37] Carboplatin/Etoposide/IfosfamideLack of efficacy and drug intolerance : case report
Reactions Weekly, 2024, 2034 (1) : 93 - 93
[38] Carboplatin/etoposide/serplulimabGastrointestinal reactions and lack of efficacy: case report
Reactions Weekly, 2024, 2037 (1) : 104 - 104
[39] Irinotecan/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1921 (1) : 159 - 159
[40] Acetylcysteine/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1842 (1) : 11 - 11

← 1 2 3 4 5 →